(Q75225101)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

title

The antiangiogenic agent Neovastat (AE-941) stimulates tissue plasminogen activator activity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

main subject

angiogenesis inhibitor

1 reference

Denis Gingras

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Dominique Labelle

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Carine Nyalendo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Dominique Boivin

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Michel Demeule

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Chantal Barthomeuf

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

Richard Béliveau

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

17 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

17 November 2019

page(s)

17-26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14707491%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1023/b:drug.0000006171.54078.3d

17 November 2019

exact match

0 references

cites work

The urokinase receptor is required for human monocyte chemotaxis in vitro

1 reference

12 December 2020

Functional evaluation of plasmin formation in primary breast cancer

1 reference

12 December 2020

Tissue-type plasminogen activator (t-PA) is stored in Weibel-Palade bodies in human endothelial cells both in vitro and in vivo

1 reference

12 December 2020

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

1 reference

12 December 2020

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

12 December 2020

Neovastat (AE-941) in refractory renal cell carcinoma patients: report of a phase II trial with two dose levels

1 reference

12 December 2020

Antiangiogenic and antimetastatic properties of Neovastat (AE-941), an orally active extract derived from cartilage tissue

1 reference

12 December 2020

Matrix proteinase inhibition by AE-941, a multifunctional antiangiogenic compound.

1 reference

12 December 2020

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma

1 reference

12 December 2020

AE-941 (Neovastat): a novel multifunctional antiangiogenic compound

1 reference

12 December 2020

In vitro and in vivo induction of antiangiogenic activity by plasminogen activators and captopril

1 reference

12 December 2020

Mechanisms of physiological fibrinolysis

1 reference

12 December 2020

A critical role of lysine residues in the stimulation of tissue plasminogen activator by denatured proteins and fibrin clots

1 reference

12 December 2020

No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer

1 reference

12 December 2020

Regulation of plasminogen activation by components of the extracellular matrix

1 reference

12 December 2020

Denatured proteins as cofactors for plasminogen activation

1 reference

12 December 2020

Stimulation of tissue plasminogen activator by denatured proteins and fibrin clots: a possible additional role for plasminogen activator?

1 reference

12 December 2020

Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.

1 reference

12 December 2020

Regulation of plasminogen activator secretion in mouse peritoneal macrophages. I. - Role of serum studied by a new spectrophotometric assay for plasminogen activators

1 reference

12 December 2020

Neovastat, a naturally occurring multifunctional antiangiogenic drug, in phase III clinical trials

1 reference

12 December 2020

Studies on the kinetics of plasminogen activation by tissue plasminogen activator

1 reference

12 December 2020

Angiostatin inhibits endothelial and melanoma cellular invasion by blocking matrix-enhanced plasminogen activation

1 reference

12 December 2020

Biological significance of tissue plasminogen activator content in brain tumors

1 reference

12 December 2020

High tPA-expression in primary melanoma of the limb correlates with good prognosis

1 reference

12 December 2020

The antiangiogenic agent Neovastat (AE-941) induces endothelial cell apoptosis.

1 reference

12 December 2020

Proteolysis and cell migration: creating a path?

1 reference

12 December 2020

Inhibitory effect on the establishment of hepatic metastasis by transduction of the tissue plasminogen activator gene to murine colon cancer

1 reference

12 December 2020

Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice

1 reference

12 December 2020

Amyloid endostatin induces endothelial cell detachment by stimulation of the plasminogen activation system

1 reference

12 December 2020

Tissue-type plasminogen activator is a multiligand cross-beta structure receptor

1 reference

12 December 2020

The antiangiogenic agent neovastat (AE-941) inhibits vascular endothelial growth factor-mediated biological effects.

1 reference

12 December 2020

Angiostatin generation by human tumor cell lines: involvement of plasminogen activators.

1 reference

12 December 2020